Oral SERD Therapy in ER+/HER2- Metastatic Breast Cancer

home / peer-exchange / oral-serd-therapy-in-er-her2-metastatic-breast-cancer

A panel of experts explore a novel class of medications for patients with metastatic breast cancer, the oral selective estrogen receptor degrader (SERDs).

© 2023 MJH Life Sciences
AJMC®
All rights reserved.